Direct medical costs and their predictors in patients with rheumatoid arthritis

E-ISSN： 1529-0131|48|10|2750-2762

ISSN： 0004-3591

Source： Arthritis & Rheumatism, Vol.48, Iss.10, 2003-10, pp. : 2750-2762

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Changes in Utilization and Costs for Patients with Rheumatoid Arthritis, 1997 to 2006

By Birnbaum Howard G.

PharmacoEconomics, Vol. 30, Iss. 4, 2012-04 ,pp. : 323-336

Adis International

Access to resources Recommend Favorite

A Review of the Direct Costs of Rheumatoid Arthritis: Managed Care versus Fee-for-Service Settings

By Lubeck D.P.

PharmacoEconomics, Vol. 19, Iss. 8, 2001-01 ,pp. : 811-818

Adis International

Access to resources Recommend Favorite

Tacrolimus: In Patients with Rheumatoid Arthritis

By Curran Monique P. Perry Caroline M.

Drugs, Vol. 65, Iss. 7, 2005-01 ,pp. : 993-1001

Adis International

Access to resources Recommend Favorite

Medical Management of Children with Juvenile Rheumatoid Arthritis

By Cassidy J.T.

Drugs, Vol. 58, Iss. 5, 1999-11 ,pp. : 831-850

Adis International

Access to resources Recommend Favorite

Approaches to Identifying Genetic Predictors of Clinical Outcome in Rheumatoid Arthritis

By Barton A. John S.

American Journal of PharmacoGenomics, Vol. 3, Iss. 3, 2003-01 ,pp. : 181-191

Adis International

Access to resources Recommend Favorite